Exploration and Characterization of the Antimalarial Activity of Pyrimidine‐2,4‐Diamines for which Resistance is Mediated by the ABCI3 Transporter
ChemMedChem · 2026-01 · 21 (1)
DOI: 10.1002/cmdc.202500739 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 12.12.2025. Verfasst von Mahta Mansouri und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Australia. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Pyrimidines, Diamines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Medicines for Malaria Venture.
Abstract (Originalsprache)
The spread of drug‐resistant Plasmodium strains is diminishing the effectiveness of current antimalarials, highlighting the importance of discovering new therapeutics with novel targets. A screen of the Jumpstarter library against P. falciparum identified W482 with a pyrimidine‐2,4‐diamine scaffold. Structure‐activity relationships reveal the importance of the pyrimidine core and its endocyclic nitrogen, while alternative amines are tolerated in the 4‐position. Bulky and hydrophobic carboxamides or substituted phenyl ureas display the most potent antiplasmodial activity. Resistance selection and whole genome sequencing reveal an amplification of the gene encoding the ABCI3 transporter protein W482‐resistant parasites. W482 is found to exhibit greater activity against parasites with reduced expression of ABCI3, confirming that resistance is related to the transporter. W482 arrests asexual parasites at the ring to trophozoite transition stage and exhibits a fast‐killing profile with a lag phase of 24 h. Improving the antiparasitic activity alongside metabolic stability and solubility remains a challenge in the future development of the pyrimidine‐2,4‐diamine class.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Australia.
- Department of Medical Biology, The University of Melbourne, Parkville, 3010, Australia.
- Research School of Biology, Australian National University, Canberra, 2601, Australia.
- Global Health Medicines R &D, GSK, Tres Cantos, 28760, Spain.
- MMV Medicines for Malaria Venture, 1215, Geneva, Switzerland.
- Emerging Science & Innovation, Discovery Sciences, Janssen R&D LLC, La Jolla, CA, 92121, USA.
ORCID-Profile: Mahta Mansouri, Madeline G Dans, Katie Loi, Kate E Jarman, Deyun Qiu, Adele M Lehane, Benigno Crespo, Franciso-Javier Gamo, Delphine Baud, Stephen Brand, Alan F Cowman, Brad E Sleebs
Förderung
- National Health and Medical Research Council
- Medicines for Malaria Venture
Zitieren
APA
Mansouri, M., Dans, M. G., Low, Z., Loi, K., Jarman, K. E., Penington, J. S., Qiu, D., Lehane, A. M., Crespo, B., Gamo, F. J., Baud, D., Brand, S., Jackson, P. F., Cowman, A. F., & Sleebs, B. E. (2026). Exploration and Characterization of the Antimalarial Activity of Pyrimidine‐2,4‐Diamines for which Resistance is Mediated by the ABCI3 Transporter. ChemMedChem, 21(1). https://doi.org/10.1002/cmdc.202500739
Vancouver
Mansouri M, Dans MG, Low Z, Loi K, Jarman KE, Penington JS, et al. Exploration and Characterization of the Antimalarial Activity of Pyrimidine‐2,4‐Diamines for which Resistance is Mediated by the ABCI3 Transporter. ChemMedChem. 2026;21(1). doi:10.1002/cmdc.202500739
BibTeX
@article{Mansouri2026,
author = {Mansouri, Mahta and Dans, Madeline G and Low, Zijun and Loi, Katie and Jarman, Kate E and Penington, Jocelyn S and Qiu, Deyun and Lehane, Adele M and Crespo, Benigno and Gamo, Franciso-Javier and Baud, Delphine and Brand, Stephen and Jackson, Paul F and Cowman, Alan F and Sleebs, Brad E},
title = {Exploration and Characterization of the Antimalarial Activity of Pyrimidine‐2,4‐Diamines for which Resistance is Mediated by the ABCI3 Transporter},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {1},
doi = {10.1002/cmdc.202500739}
}
EUVIMED